Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Post by newdaydawningon Aug 21, 2019 4:32pm
172 Views
Post# 30052196

If you're long, it's better to buy below financing

If you're long, it's better to buy below financingFor long holders, it should be pretty obvious that 27-cent open market shares are a better deal than 30-cent units, even with the incredibly generous warrant.

I just added another 120K today to boost my position to 700K. At 27 cents, that's a 10% discount to the offering and a 23% discount to the warrants.

I'm fully tapped out now, and expect many other TLT longs are in a similar position.

I've never been more bullish about a stock than this one.

TLT's success in treating NMIBC during Ph1 will almost assuredly be repeated in Ph2.

And the reason for that is that science nevers stops advancing. Think of how far TLT's treatment has progressed since the last clinical patient more than 18 months ago.

Looking forward to three years out when the data confirms categorically what everybody already knows: TLT has a disruptive, transformative treatment for cancer.


Bullboard Posts